CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionOperating margin is -87.4%, lower than 95% of its Medical Instruments & Supplies peers (median 9.3%)
- FinancialsLow earnings quality
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
7.41BCNY1.10B · vs all stocks (USD)
Revenue (TTM)
272.96MCNY40.48M · vs all stocks (USD)
Profit Margin
-79.13%vs Medical Instruments & Supplies peers
Beta
0.5630xvs all stocks
52-Week Change
-18.81%vs all stocks
Market Capitalization
7.41BCNY1.10B · vs all stocks (USD)
Enterprise Value
7.52BCNY1.12B · vs all stocks (USD)
Price to Sales (TTM)
27.53xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
6.35xvs Medical Instruments & Supplies peers
Enterprise to Revenue
27.55xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-44.13xvs Medical Instruments & Supplies peers
Gross Margin
63.87%vs Medical Instruments & Supplies peers
Profit Margin
-79.13%vs Medical Instruments & Supplies peers
Operating Margin
-87.39%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-7.87%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-18.50%vs Medical Instruments & Supplies peers
Revenue (TTM)
272.96MCNY40.48M · vs all stocks (USD)
Revenue per Share (TTM)
0.5900CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-10.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
181.83MCNY26.97M · vs all stocks (USD)
EBITDA (TTM)
-170.36MCNY-25.26M · vs all stocks (USD)
Net Income (TTM)
-215.99MCNY-32.03M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-39.21%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
-122.20MCNY-18.12M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-11.51MCNY-1.71M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
39.52MCNYFY2025 · Dec 31, 2025Revenue
278.82MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
85.81MCNYFY2025 · Dec 31, 2025Gross Profit
193.00MCNYFY2025 · Dec 31, 2025Operating Income
-143.77MCNY-21.32M · vs all stocks (USD)
Pre-tax Income
-154.69MCNYFY2025 · Dec 31, 2025Income Tax Expense
41.42MCNYFY2025 · Dec 31, 2025Net Income
-196.11MCNYFY2025 · Dec 31, 2025EBIT
-142.53MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-98.48MCNYFY2025 · Dec 31, 2025Research & Development
123.17MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
128.78MCNYFY2025 · Dec 31, 2025Other Operating Expenses
3.83MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.51MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
12.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.4000CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.4000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
456.87MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
456.87MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-196.11MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
13.36MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-141.52MCNYFY2025 · Dec 31, 2025Free Cash Flow
-171.23MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
264.15MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-196.11MCNYFY2025 · Dec 31, 2025Other Non-cash Items
21.00MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
8.62MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
24.97MCNYFY2025 · Dec 31, 2025Capital Expenditures
-29.71MCNYFY2025 · Dec 31, 2025Purchase of Investments
-254.50MCNYFY2025 · Dec 31, 2025Sale of Investments
209.52MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-74.70MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
58.43MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-60.94MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-7.18MCNYFY2025 · Dec 31, 2025Other Financing Charges
114.06MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
104.37MCNYFY2025 · Dec 31, 2025Shares Outstanding
455.99MSharesUpdated Aug 19, 2026Float Shares
319.34MSharesUpdated Aug 19, 2026% Held by Insiders
31.16%vs all stocks
% Held by Institutions
15.17%vs all stocks
Total Cash (MRQ)
208.08MCNY30.86M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4560CNYUpdated Aug 19, 2026Total Debt (MRQ)
190.38MCNY28.23M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1597xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.83xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
2.54CNYUpdated Aug 19, 2026Total Assets
1.71BCNY254.23M · vs all stocks (USD)
Total Current Assets
442.89MCNYFY2025 · Dec 31, 2025Total Liabilities
488.34MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.27BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
324.76MCNYFY2025 · Dec 31, 2025Total Current Liabilities
163.58MCNYFY2025 · Dec 31, 2025Cash
264.15MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
264.15MCNYFY2025 · Dec 31, 2025Other Short-term Investments
41.65MCNYFY2025 · Dec 31, 2025Accounts Receivable
34.76MCNYFY2025 · Dec 31, 2025Inventory
47.29MCNYFY2025 · Dec 31, 2025Accounts Payable
45.75MCNYFY2025 · Dec 31, 2025Short-term Debt
39.49MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.60MCNYFY2025 · Dec 31, 2025Long-term Debt
157.60MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
112.01MCNYFY2025 · Dec 31, 2025Common Stock (Book)
455.99MCNYFY2025 · Dec 31, 2025Retained Earnings
-735.36MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.23BCNY181.81M · vs all stocks (USD)
52-Week Low
14.14CNYUpdated Aug 19, 202652-Week High
29.05CNYUpdated Aug 19, 202652-Week Change
-18.81%vs all stocks
Beta
0.5630xvs all stocks
50-Day MA
17.87CNYUpdated Aug 19, 2026200-Day MA
19.64CNYUpdated Aug 19, 2026Avg 10-Day Volume
7.98MSharesUpdated Aug 19, 2026Avg 30-Day Volume
7.13MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.4700CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -87.4%, lower than 95% of its Medical Instruments & Supplies peers (median 9.3%)Significant
Operating margin: -0.87Industry median: 0.09Industry P5: -0.20Peers compared: 35.00
Profit margin is -79.1%, lower than 95% of its Medical Instruments & Supplies peers (median 7.4%)Significant
Profit margin: -0.79Industry median: 0.07Industry P5: -0.21Peers compared: 35.00
Return on equity is -18.5%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: -0.19Industry median: 0.06Industry P5: -0.18Peers compared: 35.00
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 27.53Revenue Growth YoY: -0.10
High gross margins eroded by operating costsNotable
Gross Margin: 0.64Profit Margin: -0.79
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.67
Altman Z-Score 8.58: safe zoneNotable
Altman Z-Score: 8.58
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Tres Tentos Agroindustrial S.A.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
RNBC New Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changsha Dian New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangyin Hengrun Heavy Industries Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Chuzhou Duoli Automotive Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Metsä Board Oyj B
Tier 1ProductionThroughput-Bound ConversionFlowRule
Rastar Environmental Protection Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Saurer Intelligent Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
North Huajin Chemical Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changyuan Technology Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking